26 related articles for article (PubMed ID: 25265435)
1. The miR-155-PU.1 axis acts on Pax5 to enable efficient terminal B cell differentiation.
Lu D; Nakagawa R; Lazzaro S; Staudacher P; Abreu-Goodger C; Henley T; Boiani S; Leyland R; Galloway A; Andrews S; Butcher G; Nutt SL; Turner M; Vigorito E
J Exp Med; 2014 Oct; 211(11):2183-98. PubMed ID: 25288398
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma.
Slezak-Prochazka I; Kluiver J; de Jong D; Smigielska-Czepiel K; Kortman G; Winkle M; Rutgers B; Koerts J; Visser L; Diepstra A; Kroesen BJ; van den Berg A
Oncotarget; 2016 Jan; 7(3):2391-400. PubMed ID: 26497687
[TBL] [Abstract][Full Text] [Related]
3. BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemia.
Yaktapour N; Meiss F; Mastroianni J; Zenz T; Andrlova H; Mathew NR; Claus R; Hutter B; Fröhling S; Brors B; Pfeifer D; Pantic M; Bartsch I; Spehl TS; Meyer PT; Duyster J; Zirlik K; Brummer T; Zeiser R
J Clin Invest; 2014 Nov; 124(11):5074-84. PubMed ID: 25329694
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of miR-125b and miR-155b and their relationship with MYC and TP53 in diffuse large B-cell lymphoma: cell-of-origin classification matters.
Filho EHCN; Zancheta SB; de Barros Silva PG; Rodríguez Burbano RM; Rabenhorst SHB
J Clin Exp Hematop; 2023; 63(3):164-172. PubMed ID: 37766562
[TBL] [Abstract][Full Text] [Related]
5. Potential Pathogenic Impact of Cow's Milk Consumption and Bovine Milk-Derived Exosomal MicroRNAs in Diffuse Large B-Cell Lymphoma.
Melnik BC; Stadler R; Weiskirchen R; Leitzmann C; Schmitz G
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047075
[TBL] [Abstract][Full Text] [Related]
6. The value of circulating microRNAs for early diagnosis of B-cell lymphoma: A case-control study on historical samples.
Jørgensen S; Paulsen IW; Hansen JW; Tholstrup D; Hother C; Sørensen E; Petersen MS; Nielsen KR; Rostgaard K; Larsen MAH; Brown PN; Ralfkiær E; Homburg KM; Hjalgrim H; Erikstrup C; Ullum H; Troelsen J; Grønbæk K; Pedersen OB
Sci Rep; 2020 Jun; 10(1):9637. PubMed ID: 32541886
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of microRNA‑21 expression inhibits proliferation, and induces G1 arrest and apoptosis via the PTEN/AKT pathway in SKM‑1 cells.
Li G; Song Y; Li G; Ren J; Xie J; Zhang Y; Gao F; Mu J; Dai J
Mol Med Rep; 2018 Sep; 18(3):2771-2779. PubMed ID: 30015844
[TBL] [Abstract][Full Text] [Related]
8. miR-155 as a Biomarker in B-Cell Malignancies.
Due H; Svendsen P; Bødker JS; Schmitz A; Bøgsted M; Johnsen HE; El-Galaly TC; Roug AS; Dybkær K
Biomed Res Int; 2016; 2016():9513037. PubMed ID: 27294145
[TBL] [Abstract][Full Text] [Related]
9. A spindle cell variant of diffuse large B-cell lymphoma is characterized by T-cell/myofibrohistio-rich stromal alterations: analysis of 10 cases and a review of the literature.
Kimura Y; Arakawa F; Kiyasu J; Miyoshi H; Yoshida M; Ichikawa A; Nakashima S; Ishibashi Y; Niino D; Sugita Y; Ishiyama K; Higuchi M; Takasaki Y; Shimomura T; Koike C; Kuwahara N; Fujikawa K; Ohshima K
Eur J Haematol; 2012 Oct; 89(4):302-10. PubMed ID: 22738254
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of aberrant microRNAs expression in predicting disease relapse/refractoriness to treatment in diffuse large B-cell lymphoma: A meta-analysis.
Ting CY; Liew SM; Price A; Gan GG; Bee-Lan Ong D; Tan SY; Bee PC
Crit Rev Oncol Hematol; 2019 Dec; 144():102818. PubMed ID: 31733445
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of miR-155 and miR-21 in tumor and stroma cells in diffuse large B-cell lymphoma.
Munch-Petersen HD; Ralfkiaer U; Sjö LD; Hother C; Asmar F; Nielsen BS; Brown P; Ralfkiaer E; Grønbæk K
Appl Immunohistochem Mol Morphol; 2015 Mar; 23(3):188-95. PubMed ID: 25265435
[TBL] [Abstract][Full Text] [Related]
12. [Expression of microRNA-223 and its clinicopathologic correlation in diffuse large B-cell lymphoma].
Yao XX; Wang JF; Wang YH; Gao N
Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):366-70. PubMed ID: 22932402
[TBL] [Abstract][Full Text] [Related]
13. [Significance of microRNA-146b-5p in diffuse large B-cell lymphoma and its relationship with risk assessment].
Cao QW; Li HY; Yao XX; Wang JF
Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1010-4. PubMed ID: 23363792
[TBL] [Abstract][Full Text] [Related]
14. Angiomirs expression profiling in diffuse large B-Cell lymphoma.
Borges NM; do Vale Elias M; Fook-Alves VL; Andrade TA; de Conti ML; Macedo MP; Begnami MD; Campos AH; Etto LY; Bortoluzzo AB; Alves AC; Young KH; Colleoni GW
Oncotarget; 2016 Jan; 7(4):4806-16. PubMed ID: 26683099
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA signature is indicative of long term prognosis in diffuse large B-cell lymphoma.
Shepshelovich D; Ram R; Uziel O; Kushnir M; Lithwick-Yanai G; Hoshen M; Feinmesser M; Bairey O; Lahav M
Leuk Res; 2015 Jun; 39(6):632-7. PubMed ID: 25866097
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
